Lower levels of inhibin A and pro- C during the luteal phase after triggering oocyte maturation with a gonadotropin-releasing hormone agonist versus human chorionic gonadotropin

By Nevo O.   Eldar-Geva T.a.   Kol S.   Itskovitz-Eldor J.  

Fertility and Sterility, Vol. 79, Iss. 5, 2003-05 ,pp. : 1123-1128

Elsevier

Access to resources Recommend Favorite

Sperm to zona pellucida binding depends on the use of a gonadotropin-releasing hormone agonist or a gonadotropin-releasing hormone antagonist

By Schroder A.K.   Schopper B.   Al-Hasani S.   Loning M.   Diedrich K.   Ludwig M.  

Fertility and Sterility, Vol. 79, Iss. 3, 2003-03 ,pp. : 648-650

Elsevier

Access to resources Recommend Favorite

Effects of a Gonadotropin-Releasing Hormone agonist and Follicle Stimulating Hormone on the incidence of apoptosis in human luteinized granulosa cells

By Sifer C.   Blanc-Layrac G.   Bringuier A.-F.   Porcher R.   Madelenat P.   Feldmann G.   Benifla J.-L.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 110, Iss. 1, 2003-09 ,pp. : 43-48

Elsevier

Access to resources Recommend Favorite

Gonadotropin-releasing hormone agonist therapy induces apoptosis in uterine leiomyoma

By Higashijima T.   Kataoka A.   Nishida T.   Yakushiji M.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 68, Iss. 1, 1996-09 ,pp. : 169-173

Elsevier

Access to resources Recommend Favorite

Two consecutive pregnancies during inadvertent gonadotropin-releasing hormone agonist desensitization

By Platteau P.   Gabbe M.   Talbot M.   Healy D.  

Fertility and Sterility, Vol. 73, Iss. 6, 2000-06 ,pp. : 1244-1246

Elsevier

Access to resources Recommend Favorite